Anascorp injections, wrsu

Ended Awarded Last action

Contract number
75H71220F28005
Awardee
Awarding agency
Obligated
$29,744

Award facts

Contract value 100% obligated
$29,744.28 Current and potential, with all options
Completion date 100% complete
Current and potential, with all options
Set-aside
No set-aside
Competition
Full and Open Competition Multiple Award, Fair Opportunity
Pricing
Firm Fixed Price
Place of performance
Franklin, TN 37067, USA

Award details come from SAM.gov/FPDS.

Transactions

Action Obligated Date
Funding Only Action P00001 $359
Original award $29,385

About this award

Rare Disease Therapeutics, Inc. was awarded a $29,744.28 firm fixed price call against the company's GSA Schedule Pharmaceuticals and Drugs (FSS-61-IB) contract by the Department of Health and Human Services Indian Health Service. The contract calls for the delivery of ANASCORP INJECTIONS, WRSU to support the agency's BPA AREA WIDE program. Performance will occur in Franklin, Tennessee under a May 2020 awarded, May 2021 completing order. No set-aside designation was applied to this contract call.

Quick answers

Who was awarded contract 75H71220F28005?

75H71220F28005 was awarded to Rare Disease Therapeutics, Inc. by Indian Health Service (Department of Health and Human Services) on May 22, 2020.

How much is contract 75H71220F28005 worth?

The government has obligated $29,744 on 75H71220F28005.

Is contract 75H71220F28005 an order under another contract?

Yes. 75H71220F28005 is a BPA call under 36F79718D0404-75H71219A00003, a blanket purchase agreement, on Pharmaceuticals and Drugs (FSS-61-IB).

Was contract 75H71220F28005 competed?

The extent of competition for 75H71220F28005 was full and open competition.

On GovTribe

See this award's full record

  • Every transaction and funding action
  • The awardee's other awards and teaming partners
  • Similar awards and recompete opportunities
  • Ask GovTribe AI about this award